Read + Share
Amedeo Smart
Independent Medical Education
Czajkowska K, Zbroch E, Bielach-Bazyluk A, Koc-Zorawska E, et al. MID-REGIONAL PROADRENOMEDULLIN (MR-PROADM) AS A BIOMARKER IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND HYPERTENSION - STUDY CONTINUATION. J Hypertens 2022;40.PMID: 36026759
Email
LinkedIn
Facebook
Twitter
Privacy Policy